A detailed history of 1492 Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, 1492 Capital Management LLC holds 171,182 shares of ADMA stock, worth $2.66 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
171,182
Previous 95,803 78.68%
Holding current value
$2.66 Million
Previous $1.74 Million 43.86%
% of portfolio
1.08%
Previous 0.88%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$14.66 - $19.91 $1.11 Million - $1.5 Million
75,379 Added 78.68%
171,182 $2.51 Million
Q2 2025

Aug 13, 2025

BUY
$17.6 - $24.51 $822,219 - $1.15 Million
46,717 Added 95.17%
95,803 $1.74 Million
Q1 2025

May 06, 2025

BUY
$15.44 - $20.61 $757,887 - $1.01 Million
49,086 New
49,086 $973,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.